Niacin for Stroke Prevention: Evidence and Rationale

作者: Adrienne Keener , Nerses Sanossian

DOI: 10.1111/J.1755-5949.2008.00055.X

关键词:

摘要: Low levels of high-density lipoprotein (HDL) cholesterol are associated with increased atherothrombotic events, including stroke. Niacin is a safe and effective means raising HDL, yet its role in stroke prevention not well characterized. The purpose the study to determine niacin prevention. A search PUBMED database using keywords niacin, stroke, atherosclerosis, and/or carotid artery was undertaken identify studies for review. National guidelines from American Heart Asssociation Cholesterol Education Program were reviewed. Treatment low serum HDL (<40 mg/dL) an identified goal dyslipidemic therapy. reducing cardiovascular events individuals high vascular risk can be used treatment patients HDL. safely combination statins, first-line secondary reduction, efficacy. Studies needed better define extended-release (ER) alone or should considered atherosclerotic mechanisms HDL-C levels.

参考文章(56)
Peter H Jones, Michael H Davidson, Evan A Stein, Harold E Bays, James M McKenney, Elinor Miller, Valerie A Cain, James W Blasetto, Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial) The American Journal of Cardiology. ,vol. 92, pp. 152- 160 ,(2003) , 10.1016/S0002-9149(03)00530-7
Marshall B. Elam, Donald B. Hunninghake, Kathryn B. Davis, Rekha Garg, Craig Johnson, Debra Egan, John B. Kostis, David S. Sheps, Eliot A. Brinton, for the ADMIT Investigators, Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease JAMA. ,vol. 284, pp. 1263- 1270 ,(2000) , 10.1001/JAMA.284.10.1263
Leon A. Simons, John McCallum, Yechiel Friedlander, Judith Simons, Risk Factors for Ischemic Stroke: Dubbo Study of the Elderly Stroke. ,vol. 29, pp. 1341- 1346 ,(1998) , 10.1161/01.STR.29.7.1341
M Dominique Ashen, Roger S Blumenthal, None, Low HDL Cholesterol Levels New England Journal of Medicine. ,vol. 353, pp. 1252- 1260 ,(2005) , 10.1056/NEJMCP044370
Antonio M. Gotto, Eliot A. Brinton, Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report and update Journal of the American College of Cardiology. ,vol. 43, pp. 717- 724 ,(2004) , 10.1016/J.JACC.2003.08.061
, High-dose atorvastatin after stroke or transient ischemic attack. The New England Journal of Medicine. ,vol. 355, pp. 549- 559 ,(2006) , 10.1056/NEJMOA061894
Steven E Nissen, Jean-Claude Tardif, Stephen J Nicholls, James H Revkin, Charles L Shear, William T Duggan, Witold Ruzyllo, William B Bachinsky, Gabriel P Lasala, E Murat Tuzcu, None, Effect of Torcetrapib on the Progression of Coronary Atherosclerosis The New England Journal of Medicine. ,vol. 356, pp. 1304- 1316 ,(2007) , 10.1056/NEJMOA070635